thyssenkrupp nucera's first quarter of the new financial year 2024/2025 showcased remarkable success with strong sales and EBIT growth. The company's focus on highly efficient electrolysis technologies, especially in the green hydrogen segment, led to a 27% increase in sales to EUR 262 million. Despite challenges such as regulatory uncertainties and high start-up costs in the hydrogen market, thyssenkrupp nucera's EBIT improved significantly to EUR 8 million, primarily driven by the enhanced gross margin in the green hydrogen division. The company's investment in R&D, with a focus on alkaline water electrolysis and solid oxide electrolysis, highlights its commitment to innovation. thyssenkrupp nucera also signed strategic agreements, including a partnership with Chlorum Solutions in the U.S. and a memorandum of understanding with Hydrom in Oman. These partnerships aim to expand the use of green hydrogen and strengthen the company's market position. Despite a decrease in order intake, the company remains optimistic about the growth prospects for green hydrogen and continues to invest in expanding its workforce and global presence.